🇨🇦 YTTRIUM Y 90 IBRITUMOMAB TIUXETAN in Canada

YTTRIUM Y 90 IBRITUMOMAB TIUXETAN (YTTRIUM Y 90 IBRITUMOMAB TIUXETAN) regulatory status in Canada.

Marketing authorisation

YTTRIUM Y 90 IBRITUMOMAB TIUXETAN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is YTTRIUM Y 90 IBRITUMOMAB TIUXETAN approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for YTTRIUM Y 90 IBRITUMOMAB TIUXETAN in Canada?

Marketing authorisation holder not available in our data.